Xueyan Yuan1, Xinxing Lu1, Yali Chao1, Jennifer Beck2,3,4, Christer Sinderby5,3,4, Jianfeng Xie1, Yi Yang1, Haibo Qiu6, Ling Liu7. 1. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. 2. Department of Pediatrics, University of Toronto, Toronto, Canada. 3. Department of Critical Care, Keenan Research Centre for Biomedical Science of St. Michael's Hospital, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B1W8, Canada. 4. Institute for Biomedical Engineering and Science Technology (iBEST), Ryerson University and St-Michael's Hospital, Toronto, Canada. 5. Department of Medicine and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada. 6. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. haiboq2000@163.com. 7. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. liulingdoctor@126.com.
Abstract
BACKGROUND: Prolonged ventilatory support is associated with poor clinical outcomes. Partial support modes, especially pressure support ventilation, are frequently used in clinical practice but are associated with patient-ventilation asynchrony and deliver fixed levels of assist. Neurally adjusted ventilatory assist (NAVA), a mode of partial ventilatory assist that reduces patient-ventilator asynchrony, may be an alternative for weaning. However, the effects of NAVA on weaning outcomes in clinical practice are unclear. METHODS: We searched PubMed, Embase, Medline, and Cochrane Library from 2007 to December 2020. Randomized controlled trials and crossover trials that compared NAVA and other modes were identified in this study. The primary outcome was weaning success which was defined as the absence of ventilatory support for more than 48 h. Summary estimates of effect using odds ratio (OR) for dichotomous outcomes and mean difference (MD) for continuous outcomes with accompanying 95% confidence interval (CI) were expressed. RESULTS: Seven studies (n = 693 patients) were included. Regarding the primary outcome, patients weaned with NAVA had a higher success rate compared with other partial support modes (OR = 1.93; 95% CI 1.12 to 3.32; P = 0.02). For the secondary outcomes, NAVA may reduce duration of mechanical ventilation (MD = - 2.63; 95% CI - 4.22 to - 1.03; P = 0.001) and hospital mortality (OR = 0.58; 95% CI 0.40 to 0.84; P = 0.004) and prolongs ventilator-free days (MD = 3.48; 95% CI 0.97 to 6.00; P = 0.007) when compared with other modes. CONCLUSIONS: Our study suggests that the NAVA mode may improve the rate of weaning success compared with other partial support modes for difficult to wean patients.
BACKGROUND: Prolonged ventilatory support is associated with poor clinical outcomes. Partial support modes, especially pressure support ventilation, are frequently used in clinical practice but are associated with patient-ventilation asynchrony and deliver fixed levels of assist. Neurally adjusted ventilatory assist (NAVA), a mode of partial ventilatory assist that reduces patient-ventilator asynchrony, may be an alternative for weaning. However, the effects of NAVA on weaning outcomes in clinical practice are unclear. METHODS: We searched PubMed, Embase, Medline, and Cochrane Library from 2007 to December 2020. Randomized controlled trials and crossover trials that compared NAVA and other modes were identified in this study. The primary outcome was weaning success which was defined as the absence of ventilatory support for more than 48 h. Summary estimates of effect using odds ratio (OR) for dichotomous outcomes and mean difference (MD) for continuous outcomes with accompanying 95% confidence interval (CI) were expressed. RESULTS: Seven studies (n = 693 patients) were included. Regarding the primary outcome, patients weaned with NAVA had a higher success rate compared with other partial support modes (OR = 1.93; 95% CI 1.12 to 3.32; P = 0.02). For the secondary outcomes, NAVA may reduce duration of mechanical ventilation (MD = - 2.63; 95% CI - 4.22 to - 1.03; P = 0.001) and hospital mortality (OR = 0.58; 95% CI 0.40 to 0.84; P = 0.004) and prolongs ventilator-free days (MD = 3.48; 95% CI 0.97 to 6.00; P = 0.007) when compared with other modes. CONCLUSIONS: Our study suggests that the NAVA mode may improve the rate of weaning success compared with other partial support modes for difficult to wean patients.
Authors: N R MacIntyre; D J Cook; E W Ely; S K Epstein; J B Fink; J E Heffner; D Hess; R D Hubmayer; D J Scheinhorn Journal: Chest Date: 2001-12 Impact factor: 9.410
Authors: Hannah Wunsch; Derek C Angus; David A Harrison; Walter T Linde-Zwirble; Kathryn M Rowan Journal: Am J Respir Crit Care Med Date: 2011-03-25 Impact factor: 21.405
Authors: Matthew B Hudson; Ashley J Smuder; W Bradley Nelson; Christian S Bruells; Sanford Levine; Scott K Powers Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598
Authors: Oscar Peñuelas; Fernando Frutos-Vivar; Cristina Fernández; Antonio Anzueto; Scott K Epstein; Carlos Apezteguía; Marco González; Nicholas Nin; Konstantinos Raymondos; Vinko Tomicic; Pablo Desmery; Yaseen Arabi; Paolo Pelosi; Michael Kuiper; Manuel Jibaja; Dimitros Matamis; Niall D Ferguson; Andrés Esteban Journal: Am J Respir Crit Care Med Date: 2011-08-15 Impact factor: 21.405
Authors: Ewan C Goligher; Martin Dres; Eddy Fan; Gordon D Rubenfeld; Damon C Scales; Margaret S Herridge; Stefannie Vorona; Michael C Sklar; Nuttapol Rittayamai; Ashley Lanys; Alistair Murray; Deborah Brace; Cristian Urrea; W Darlene Reid; George Tomlinson; Arthur S Slutsky; Brian P Kavanagh; Laurent J Brochard; Niall D Ferguson Journal: Am J Respir Crit Care Med Date: 2018-01-15 Impact factor: 21.405
Authors: Philipp G H Metnitz; Barbara Metnitz; Rui P Moreno; Peter Bauer; Lorenzo Del Sorbo; Christoph Hoermann; Susana Afonso de Carvalho; V Marco Ranieri Journal: Intensive Care Med Date: 2009-03-14 Impact factor: 17.440
Authors: Sanford Levine; Taitan Nguyen; Nyali Taylor; Michael E Friscia; Murat T Budak; Pamela Rothenberg; Jianliang Zhu; Rajeev Sachdeva; Seema Sonnad; Larry R Kaiser; Neal A Rubinstein; Scott K Powers; Joseph B Shrager Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245